[go: up one dir, main page]

NO20072893L - Solid oral contraceptive - Google Patents

Solid oral contraceptive

Info

Publication number
NO20072893L
NO20072893L NO20072893A NO20072893A NO20072893L NO 20072893 L NO20072893 L NO 20072893L NO 20072893 A NO20072893 A NO 20072893A NO 20072893 A NO20072893 A NO 20072893A NO 20072893 L NO20072893 L NO 20072893L
Authority
NO
Norway
Prior art keywords
dienogest
ethinyl estradiol
solid oral
released
active component
Prior art date
Application number
NO20072893A
Other languages
Norwegian (no)
Inventor
Hagen Gerecke
Sabine Fricke
Ralf Ladwig
Alexander Buske
Harald Rathe
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05003181A external-priority patent/EP1690529A1/en
Priority claimed from EP05003179A external-priority patent/EP1690543A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20072893L publication Critical patent/NO20072893L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

Disclosed is a solid peroral contraceptive drug containing 17a-cyanomethyI-17-ß-hydroxyestra-4,9-dien-3on (dienogest) at a daily dose that is equal to or smaller than 2.0 mg as one active component and 17a-ethinyl estradiol (ethinyl estradiol) at a daily dose of less than 0.03 mg as another active component along with one or several pharmaceutically acceptable carriers. The dienogest is proportionately released in at least two phases while the ethinyl estradiol is released at the same time as the first phase of the dienogest.
NO20072893A 2005-02-15 2007-06-06 Solid oral contraceptive NO20072893L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05003181A EP1690529A1 (en) 2005-02-15 2005-02-15 Peroral solid dosage form for contraception comprising Dienogest and Ethinylestradiol
EP05003179A EP1690543A1 (en) 2005-02-15 2005-02-15 Pharmaceutical composition for contraception
PCT/EP2006/001358 WO2006087177A2 (en) 2005-02-15 2006-02-15 Solid peroral contraceptive drug

Publications (1)

Publication Number Publication Date
NO20072893L true NO20072893L (en) 2007-09-12

Family

ID=37951746

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072893A NO20072893L (en) 2005-02-15 2007-06-06 Solid oral contraceptive

Country Status (20)

Country Link
EP (1) EP1848406B1 (en)
JP (1) JP2008527019A (en)
KR (1) KR20070087141A (en)
AT (1) ATE395047T1 (en)
AU (1) AU2006215822B2 (en)
BR (1) BRPI0606297A2 (en)
CA (1) CA2594939A1 (en)
CY (1) CY1108265T1 (en)
DE (1) DE502006000771D1 (en)
DK (1) DK1848406T3 (en)
EA (1) EA200701389A1 (en)
ES (1) ES2310907T3 (en)
HR (1) HRP20080394T3 (en)
IL (1) IL184257A0 (en)
NO (1) NO20072893L (en)
PL (1) PL1848406T3 (en)
PT (1) PT1848406E (en)
RS (1) RS50597B (en)
SI (1) SI1848406T1 (en)
WO (1) WO2006087177A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2170347A1 (en) * 2007-07-31 2010-04-07 Bayer Schering Pharma Aktiengesellschaft Single-phase pharmaceutical composite preparation (dienogest and ethinyl estradiol) for oral therapy for regulation of blood pressure
JP2010529063A (en) * 2007-07-31 2010-08-26 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト Single-phase pharmaceutical complex preparations (dienogest and ethinylestradiol) for oral therapy for the regulation of blood pressure
JP6759478B2 (en) * 2019-02-13 2020-09-23 富士製薬工業株式会社 Oral solid composition, a method for producing the same, and an oral tablet obtained by the method for producing the oral solid composition.
EP3954364A1 (en) 2020-08-14 2022-02-16 Chemo Research, S.L. New modified release oral contraceptive composition
KR102652671B1 (en) 2023-12-26 2024-03-29 주식회사 스몰랩 Microsphere composition for microneedles of contraception and microneedles of contraception prepared by using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525017A1 (en) * 1995-06-28 1997-01-02 Schering Ag Pharmaceutical combination preparation, kit and method for hormonal contraception
EP0956024B1 (en) * 1996-07-26 2004-07-21 Wyeth Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen

Also Published As

Publication number Publication date
DE502006000771D1 (en) 2008-06-26
AU2006215822B2 (en) 2008-09-04
CA2594939A1 (en) 2006-08-24
JP2008527019A (en) 2008-07-24
CY1108265T1 (en) 2014-02-12
WO2006087177A2 (en) 2006-08-24
PL1848406T3 (en) 2009-06-30
PT1848406E (en) 2008-08-21
EP1848406B1 (en) 2008-05-14
EP1848406A2 (en) 2007-10-31
DK1848406T3 (en) 2008-09-15
EA200701389A1 (en) 2008-02-28
ATE395047T1 (en) 2008-05-15
SI1848406T1 (en) 2008-10-31
RS50597B (en) 2010-05-07
IL184257A0 (en) 2007-10-31
WO2006087177A8 (en) 2007-05-24
HRP20080394T3 (en) 2008-11-30
BRPI0606297A2 (en) 2009-06-09
ES2310907T3 (en) 2009-01-16
WO2006087177A3 (en) 2007-08-30
AU2006215822A1 (en) 2006-08-24
KR20070087141A (en) 2007-08-27
WO2006087177B1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
EA200900491A1 (en) USE OF ESTRADIOL VALERAT OR 17B-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL TREATMENT TO MAINTAIN AND / OR INCREASE SEXUAL TREATMENT IN THE SPECIAL WOMAN
HRP20070188B1 (en) PHARMACEUTICAL COMBINATION OF ETHINYLESTRADIOL AND DROSPIRENONE FOR USE AS A CONTRACEPTIC
HRP20090418T1 (en) PHARMACEUTICAL PREPARATION CONTAINING GESTAGENS AND / OR ESTROGENS AND 5-METHYL- (6S) -TETRAHYDROFOLATE
NO327588B1 (en) Pharmaceutical composition and composition comprising ethinylostradiol and drospirenone for use as a contraceptive
NO20072893L (en) Solid oral contraceptive
AR049197A1 (en) HORMONAL CONTRACEPTIVE CONTAINING A COMBINATION OF ETHYLINESTRADIOL AND CLORMADINONE ACETATE
HRP20100513T1 (en) MULTIPHASE CONTRACEPTION PREPARATION BASED ON NATURAL ESTROGEN
TW200638951A (en) Solid oral pharmaceutical form for contraception
UA85003C2 (en) Solid peroral contraceptive drug
EA200900829A1 (en) PHARMACEUTICAL PREPARATION FOR REDUCING ENDOMETRIOSIS
WO2008017331A3 (en) Peroral drug form comprising dienogest and ethinyl estradiol for contraception
TW200731977A (en) Use of estradiol valerate in combination with dienogest for the oral treatment of dysfunctional uterine bleeding in conjunction with oral contraception
TH80558A (en) Solid oral dosage forms for birth control
CY1112775T1 (en) USE OF VALERIAN OSTRADIOLIS IN CONNECTION WITH DIENOGEST FOR ORAL TREATMENT OF MUTRAL DISORDER BLOOD TREATMENT IN AITITA
UY29378A1 (en) PHARMACEUTICAL PREPARATION FOR ORAL ANTI-CONCEPTION
PE20091020A1 (en) USE OF A GESTAGEN IN COMBINATION WITH A ESTROGEN AND ONE OR MORE PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS / CARRIERS FOR LACTOSE-FREE ORAL CONTRACEPTION
RU2009140372A (en) NEW MODE WITH DROSPIRENONE / 17B-ESTRADIOL, PHARMACEUTICAL COMBINED PRODUCT AND KIT FOR THE PERFORMANCE OF THIS MODE
UA4315U (en) Method for treating lupus erythematosus
JO2213B1 (en) A pharmaceutical composition for use as a contraceptive

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application